OBZEFY
Dead / Abandoned — Abandoned — after publication (as of 22 May 2025)
What this means for you
This application is over — abandoned 21 May 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98771064
- Mark type
- Stylized text
- Filed
- 26 Sept 2024
- Published for opposition
- 01 Apr 2025
- Abandoned
- 21 May 2025
- Attorney of record
- Michelle Rosenberg
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for lowering cholesterol; pharmaceuticals, namely, lipid lowering agents; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, major adverse cardiac events, cholesterol-related diseases and disorders, dyslipidemia, lipid-related diseases and disorders, diabetes, age-related macular degeneration, neurodegenerative diseases and disorders, dementia, Lewy body dementia, and Alzheimer's disease
Owner
- NewAmsterdam Pharma B.V., Naarden, NL
- NewAmsterdam Pharma B.V., Naarden, NL
Prosecution history
- 30 Jul 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 22 May 2025 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
- 22 May 2025 — ABANDONMENT - AFTER PUBLICATION
- 21 May 2025 — TEAS EXPRESS ABANDONMENT RECEIVED
- 21 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 May 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 01 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Apr 2025 — PUBLISHED FOR OPPOSITION
- 26 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Mar 2025 — ASSIGNED TO EXAMINER
- 26 Sept 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Sept 2024 — NEW APPLICATION ENTERED